4//SEC Filing
Jacobs Bruce N. 4
Accession 0000950170-24-078790
CIK 0001815442other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 8:30 AM ET
Size
7.0 KB
Accession
0000950170-24-078790
Insider Transaction Report
Form 4
Jacobs Bruce N.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-06-27$2.08/sh+25,000$52,000→ 168,554 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-27−25,000→ 104,899 totalExercise: $2.08Exp: 2029-08-28→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This number includes 1,203 shares acquired under the Registrant's employee stock purchase plan on June 1, 2024.
- [F2]Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821074
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 8:30 AM ET
- Size
- 7.0 KB